Stiris Research Announces Completion of Patient Visits in Smallpox Study

London, ON — August 2021 —

Stiris Research Inc. (“Stiris”), an entrepreneurial clinical trial management company focused on the management of Phase I-IIIB trials, announces the completion of all patient visits in the long running smallpox trial.

“Stiris is thrilled that we have completed all patient visits on this eight-year trial. We are excited to see the results as we move into the closeout phase of this trial. Stiris enjoys collaborating with our Sponsor in finding ways to safely and effectively prevent communicable diseases, such as smallpox,” said Amanda Carrera, Vice President, Stiris Research, Inc.

Smallpox is an acute contagious disease caused by the variola virus. The virus can spread directly from person to person, indirectly from an infected person, and through contaminated items. Most people who get smallpox survive. However, some rare types of smallpox are almost always deadly. These more-severe forms are most common in pregnant women and children. Sometimes, smallpox causes vision loss (blindness). (

About Stiris Research

Stiris Research is an entrepreneurial Clinical Trial Management company specializing in conducting complex Phase I through IIIB trials for North American biotechnology and biopharmaceutical companies, with a focus on Oncology, CNS and Neurology. Stiris Research was formed as a result of listening to the stakeholders engaged in clinical trials, identifying their unmet needs, and developing a unique, value-based approach to address those needs.

For more information, please contact:

Marketing – Stiris Research Inc.